From Wikipedia, the free encyclopedia
Amaurosis fugax (Latin fugax meaning
fleeting, Greek amaurosis meaning
darkening, dark, or obscure) is a transient monocular visual loss.[1]
Pathophysiology and
etiology
Prior to 1990, amaurosis fugax could, "clinically, be divided
into four identifiable symptom complexes, each with its underlying
pathoetiology: embolic,
hypoperfusion, angiospasm, and
unknown."[2]
In 1990, the causes of amaurosis fugax were better refined by
Amaurosis Fugax Study Group, which has defined five distinct causes
of transient monocular blindness: embolic, hemodynamic, ocular,
neurologic, and idiopathic.[3]
Concerning the pathology underlying these causes (stay idiopathic), "some of the
more frequent causes include atheromatous disease of the internal
carotid or ophthalmic artery, vasospasm, optic neuropathies, giant
cell arteritis, angle-closure glaucoma, increased intracranial
pressure, orbital compressive disease, a steal phenomenon, and
blood hyperviscosity or hypercoagulability."[4]
Embolic and hemodynamic
origin
With respect to embolic and hemodynamic causes, this transient
monocular visual loss ultimately occurs due to a temporary
reduction in retinal artery, ophthalmic
artery, or ciliary artery blood flow, leading to
a decrease in retinal circulation which, in turn, causes retinal
hypoxia.[5]
Also, it must be noted that while, most commonly, emboli causing
amaurosis fugax are described as coming from an atherosclerotic carotid artery,
any emboli arising from vasculature preceding the retinal artery, ophthalmic
artery, or ciliary arteries may cause this
transient monocular blindness.
- Atherosclerotic carotid artery: Amaurosis fugax may
present as a type of transient ischemic attack
(TIA), during which an embolus unilaterally obstructs the lumen of
the retinal artery or ophthalmic
artery, causing a decrease in blood flow to the ipsilateral
retina. The most common source of these athero-emboli is an
atherosclerotic carotid artery.[6]
However, a severely atherosclerotic carotid artery may also cause amaurosis
fugax due to its stenosis
of blood flow, leading to ischemia when the retina is exposed to
bright light.[7]
"Unilateral visual loss in bright light may indicate ipsilateral
carotid artery occlusive disease and may reflect the inability of
borderline circulation to sustain the increased retinal metabolic
activity associated with exposure to bright light."[8]
- Atherosclerotic ophthalmic artery: Will present
similarly to an atherosclerotic internal carotid artery.
- Cardiac emboli: Thrombotic emboli arising from the
heart may also cause luminal obstruction of the retinal,
ophthalmic, and/or ciliary arteries, causing decreased blood flow
to the ipsilateral retina; examples being those arising due to (1)
atrial fibrillation, (2) valvular abnormalities including
post-rheumatic valvular disease, mitral valve prolapse, and a
bicuspid aortic valve, and (3) atrial myxomas.
- Temporary vasospasm
leading to decreased blood flow can be a cause of amaurosis
fugax.[9][10]
Generally, these episodes are brief, lasting no longer that five
minutes,[11]
and have been associated with exercise.[5][12]
These vasospastic episodes are not restricted to young and healthy
individuals. "Observations suggest that a systemic hemodynamic
challenge provoke[s] the release of vasospastic substance in the
rentinal vasculature of one eye."[11]
- Giant cell arteritis: Giant cell
arteritis can result in granulomatous inflammation within the
central rentinal artery and posterior ciliary arteries of eye,
resulting in partial or complete occlusion, leading to decreased
blood flow manifesting as amaurosis fugax. Commonly, amaurosis
fugax caused by giant cell arteritis may be associated with jaw
claudication and headache. However, it is also not uncommon for
these patients to have no other symptoms.[13]
One comprehensive review found a two to nineteen percent incidence
of amaurosis fugax among these patients.[14]
- Drug abuse-related intravascular emboli[3]
Ocular
origin
Ocular causes include:
Neurologic
origin
Neurological causes include:
- Papilledema:
"The underlying mechanism for visual obscurations in all of these
patients appear to be transient ischemia of the optic nerve head
consequent to increased tissue pressure. Axonal swelling,
intraneural masses, and increased influx of interstitial
fluid may all contribute to increases in tissue pressure in the
optic nerve head. The consequent reduction in perfusion pressure
renders the small, low-pressure vessels that supply the optic nerve
head vulnerable to compromise. Brief fluctuations in intracranial
or systemic blood pressure may then result in transient loss of
function in the eyes."[32]
Generally, this transient visual loss is also associated with a
headache and optic disk swelling.
- Multiple Sclerosis can cause amaurosis
fugax due to a unilateral conduction block, which is a result of
demyelination and inflammation of the optic nerve, and "...possibly
by defects in synaptic transmission and putative circulating
blocking factors."[33]
Symptoms
The experience of amaurosis fugax is classically described as a
transient monocular vision loss that appears as a "curtain coming down vertically
into the field of
vision in one eye;" however, this altitudinal visual loss is
relatively uncommon. In one study, only 23.8 percent of patients
with transient monocular vision loss experienced the classic
"curtain" or "shade" descending over their vision.[43]
Other descriptions of this experience include a monocular
blindness, dimming, fogging, or blurring.[44]
Total or sectorial vision loss typically lasts only a few
seconds, but may last minutes or even hours. Duration depends on
the etiology of the vision loss. Obscured vision due to papilledema
may last only seconds, while a severely atherosclerotic carotid
artery may be associated with a duration of one to ten minutes.[45]
Certainly, additional symptoms may be present with the amaurosis
fugax, and those findings will depend on the etiology of the
transient monocular vision loss.
Diagnostic
evaluation
Despite the temporary nature of the vision loss, those
experiencing amaurosis fugax are usually advised to consult a physician immediately as it
is a symptom that usually
heralds serious vascular events, including stroke.[46][47]
Restated, “because of the brief interval between the transient
event and a stroke or blindness from temporal arteritis, the workup
for transient monocular blindness should be undertaken without
delay.” If the patient has no history of giant cell arteritis, the
probability of vision preservation is high; however, the chance of
a stroke reaches that for a hemispheric TIA. Therefore,
investigation of cardiac disease is justified.[3]
A diagnostic evaluation should begin with the patient's history,
followed by a physical exam, with particular importance being paid
to the ophthalmic examination with regards to signs of ocular
ischemia. When investigating amaurosis fugax, an ophthalmologic
consult is absolutely warranted if available. Several concomitant
laboratory tests should also be ordered to investigate some of the
more common, systemic causes listed above, including a complete
blood count, erythrocyte sedimentation rate, lipid panel, and blood
glucose level. If a particular etiology is suspected based on the
history and physical, additional relevant labs should be
ordered.[3]
If laboratory tests are abnormal, a systemic disease process is
likely, and, if the ophthalmologic examination is abnormal, ocular
disease is likely. However, in the event that both of these routes
of investigation yield normal findings, or an inadequate
explanation, noninvasive duplex ultrasound studies are recommended
to identify carotid artery disease. Most episodes of amaurosis
fugax are the result of stenosis of the ipsilateral carotid
artery.[48]
With that being the case, researchers investigated how best to
evaluate these episodes of vision loss, and concluded that for
patients ranging from 36–74 years old, "...carotid artery duplex
scanning should be performed...as this investigation is more likely
to provide useful information than an extensive cardiac screening
(ECG, Holler 24-hour monitoring and precordial
echocardiography)."[48]
Additionally, concomitant head CT or MRI imaging is also
recommended to investigate the presence of a “clinically silent
cerebral embolism.”[3]
If the results of the ultrasound and intracranial imaging are
normal, “renewed diagnostic efforts may be made,” during which fluorescein angiography is an
appropriate consideration. However, carotid angiography is not
advisable in the presence of a normal ultrasound and CT.[49]
Treatment
If the diagnostic workup reveals a systemic disease process,
directed therapies to treat that underlying etiology should be
initiated. If the amaurosis fugax is caused by an atherosclerotic
lesion, aspirin is
indicated, and a carotid endarterectomy if the
stenosis is surgically accessible. Generally, if the carotid artery
is still patent, the greater the stenosis, the greater the
indication for endarterectomy. "Amaurosis fugax appears to be a
particularly favorable indication for carotid endarterectomy. Left
untreated, this event carries a high risk of stroke; after carotid
endarterectomy, which has a low operative risk, there is a very low
postoperative stroke rate."[50]
If the full diagnostic workup is completely normal, patient
observation is recommended.[3]
See also
References
- ^ Fisher CM (December 1989). "'Transient
monocular blindness' versus 'amaurosis fugax'". Neurology
39 (12): 1622–4. PMID 2685658.
- ^ Burde RM (September 1989). "Amaurosis
fugax. An overview". J Clin Neuroophthalmol
9 (3): 185–9. PMID 2529279.
- ^ a
b
c
d
e
f
g
h
i
j
"Current management of
amaurosis fugax. The Amaurosis Fugax Study Group".
Stroke 21 (2): 201–8. February 1990. PMID 2406992. http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=2406992.
- ^ Newman NJ. (1998). "Cerebrovascular disease".
in Hoyt, William Graves; Miller, Neil; Newman, Nancy J.; Walsh,
Frank. Walsh and Hoyt's Clinical Neuro-Ophthalmology.
3 (5th ed.). Baltimore: Williams & Wilkins.
pp. 3420–6. ISBN
0-683-30232-9.
- ^ a
b
Jehn A, Frank Dettwiler B,
Fleischhauer J, Sturzenegger M, Mojon DS (February 2002). "Exercise-induced vasospastic
amaurosis fugax". Arch. Ophthalmol.
120 (2): 220–2. doi:10.1001/archopht.120.2.220
(inactive 2009-12-27). PMID 11831932. http://archopht.ama-assn.org/cgi/content/extract/120/2/220.
- ^ Braat A, Hoogland PH, DeVries AC, de Mol
VanOtterloo JCA (2001). "Amaurosis Fugax and Stenosis
of the Ophthalmic Artery". Vasc Endovascular Surg
35 (2): 141–2. doi:10.1177/153857440103500210. http://ves.sagepub.com/cgi/content/abstract/35/2/141.
- ^ Kaiboriboon K, Piriyawat P, Selhorst JB
(May 2001). "Light-induced amaurosis
fugax". Am. J. Ophthalmol. 131 (5):
674–6. doi:10.1016/S0002-9394(00)00874-6. PMID 11336956. http://linkinghub.elsevier.com/retrieve/pii/S0002939400008746.
- ^ Furlan AJ, Whisnant JP, Kearns TP
(November 1979). "Unilateral visual loss in
bright light. An unusual symptom of carotid artery occlusive
disease". Arch. Neurol. 36 (11):
675–6. PMID 508123. http://archneur.ama-assn.org/cgi/pmidlookup?view=long&pmid=508123.
- ^ Ellenberger C, Epstein AD (June 1986).
"Ocular complications of atherosclerosis: what do they mean?".
Semin Neurol 6 (2): 185–93. doi:10.1055/s-2008-1041462. PMID 3332423.
- ^ Fisher M (1952). "Transient monocular
blindness associated with hemiplegia". Arch Ophthalmol.
47: 167–203.
- ^ a
b
Burger SK, Saul RF, Selhorst JB,
Thurston SE (September 1991). "Transient monocular blindness caused
by vasospasm". N. Engl. J. Med. 325 (12):
870–3. PMID 1875972.
- ^ Imes RK, Hoyt WF (1989). "Exercise-induced
transient visual events in young healthy adults". J Clin
Neuroophthalmol 9 (3): 178–80. PMID 2529277.
- ^ Hayreh SS, Podhajsky PA, Zimmerman B
(April 1998). "Occult giant cell arteritis: ocular manifestations".
Am. J. Ophthalmol. 125 (4): 521–6. doi:10.1016/S0002-9394(99)80193-7. PMID 9559738.
- ^ Goodman BW (November 1979). "Temporal
arteritis". Am. J. Med. 67 (5): 839–52.
doi:10.1016/0002-9343(79)90744-7. PMID 389046.
- ^ Giorgi D, David V, Afeltra A, Gabrieli CB
(March 2001). "Transient visual symptoms in systemic lupus
erythematosus and antiphospholipid syndrome". Ocul. Immunol.
Inflamm. 9 (1): 49–57. doi:10.1076/ocii.9.1.49.3980. PMID 11262668.
- ^ Gold D, Feiner L, Henkind P (September
1977). "Retinal arterial occlusive
disease in systemic lupus erythematosus". Arch.
Ophthalmol. 95 (9): 1580–5. PMID 901267. http://archopht.ama-assn.org/cgi/pmidlookup?view=long&pmid=901267.
- ^ Newman NM, Hoyt WF, Spencer WH (May 1974).
"Macula-sparing monocular
blackouts. Clinical and pathologic investigations of intermittent
choroidal vascular insufficiency in a case of periarteritis
nodosa". Arch. Ophthalmol. 91 (5):
367–70. PMID 4150748. http://archopht.ama-assn.org/cgi/pmidlookup?view=long&pmid=4150748.
- ^ Schwartz ND, So YT, Hollander H, Allen S,
Fye KH (1986). "Eosinophilic vasculitis leading to amaurosis fugax
in a patient with acquired immunodeficiency syndrome". Arch
Intern Med. 146 (10): 2059–60. doi:10.1001/archinte.146.10.2059. PMID 3767551.
- ^ a
b
c
d
e
Bacigalupi M (April 2006). "Amaurosis Fugax-A Clinical
Review". The Internet Journal of Allied Health Sciences and
Practice 4 (2): 1–6.
http://ijahsp.nova.edu/articles/vol4num2/Bacigalupi.pdf.
- ^ Berdel WE, Theiss W, Fink U, Rastetter J
(March 1984). "Peripheral arterial occlusion and amaurosis fugax as
the first manifestation of polycythemia vera. A case report".
Blut 48 (3): 177–80. doi:10.1007/BF00320341. PMID 6697006.
- ^ Mundall J, Quintero P, Von Kaulla KN,
Harmon R, Austin J (March 1972). "Transient monocular blindness and
increased platelet aggregability treated with aspirin. A case
report". Neurology 22 (3): 280–5. PMID 5062262.
- ^ Smith DB, Ens GE (March 1987). "Protein C deficiency: a
cause of amaurosis fugax?". J. Neurol. Neurosurg.
Psychiatr. 50 (3): 361–2. doi:10.1136/jnnp.50.3.361. PMID 3559620. PMC 1031809. http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=3559620.
- ^ Digre KB, Durcan FJ, Branch DW, Jacobson
DM, Varner MW, Baringer JR (March 1989). "Amaurosis fugax
associated with antiphospholipid antibodies". Ann. Neurol.
25 (3): 228–32. doi:10.1002/ana.410250304. PMID 2729913.
- ^ a
b
c
d
e
f
g
h
Corbett, James W.; Digre, Kathleen B.
(2003). "Amaurosis Fugax and Not So
Fugax—Vascular Disorders of the Eye". Practical viewing of
the optic disc. Oxford: Butterworth-Heinemann.
pp. 269–344. ISBN
0-7506-7289-7. http://intl.elsevierhealth.com/e-books/pdf/783.pdf.
- ^ Landi G, Calloni MV, Grazia Sabbadini M,
Mannuccio Mannucci P, Candelise L (1983). "Recurrent ischemic attacks
in two young adults with lupus anticoagulant". Stroke
14 (3): 377–9. PMID 6419415. http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=6419415.
- ^ Elias M, Eldor A (March 1984). "Thromboembolism in patients
with the 'lupus'-type circulating anticoagulant". Arch.
Intern. Med. 144 (3): 510–5. doi:10.1001/archinte.144.3.510. PMID 6367679. http://archinte.ama-assn.org/cgi/pmidlookup?view=long&pmid=6367679.
- ^ Hayreh SS, Servais GE, Virdi PS (January
1986). "Fundus lesions in malignant hypertension. V. Hypertensive
optic neuropathy". Ophthalmology 93 (1):
74–87. PMID 3951818.
- ^ a
b
Sørensen PN (August 1983).
"Amaurosis fugax. A unselected material". Acta Ophthalmol
(Copenh) 61 (4): 583–8. PMID 6637419.
- ^ Ravits J, Seybold ME (September 1984). "Transient monocular visual
loss from narrow-angle glaucoma". Arch. Neurol.
41 (9): 991–3. PMID 6477235. http://archneur.ama-assn.org/cgi/pmidlookup?view=long&pmid=6477235.
- ^ Brown GC, Shields JA (October 1981).
"Amaurosis fugax secondary to presumed cavernous hemangioma of the
orbit". Ann Ophthalmol 13 (10): 1205–9.
PMID 7316347.
- ^ Wilkes SR, Trautmann JC, DeSanto LW,
Campbell RJ (April 1979). "Osteoma: an unusual cause of amaurosis
fugax". Mayo Clin. Proc. 54 (4): 258–60.
PMID 423606.
- ^ Sadun AA, Currie JN, Lessell S (October
1984). "Transient visual obscurations with elevated optic discs".
Ann. Neurol. 16 (4): 489–94. doi:10.1002/ana.410160410. PMID 6497356.
- ^ Smith KJ, McDonald WI (October 1999). "The pathophysiology of
multiple sclerosis: the mechanisms underlying the production of
symptoms and the natural history of the disease". Philos.
Trans. R. Soc. Lond., B, Biol. Sci. 354
(1390): 1649–73. doi:10.1098/rstb.1999.0510. PMID 10603618. PMC 1692682. http://rstb.royalsocietypublishing.org/cgi/pmidlookup?view=long&pmid=10603618.
- ^ Mattsson, Lundberg (June 1999).
"Characteristics and prevalence of transient visual disturbances
indicative of migraine visual aura". Cephalalgia
19 (5): 447.
- ^ Cologno D, Torelli P, Manzoni GC (October
2002). "Transient visual
disturbances during migraine without aura attacks".
Headache 42 (9): 930–3. doi:10.1046/j.1526-4610.2002.02216.x. PMID 12390623. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0017-8748&date=2002&volume=42&issue=9&spage=930.
- ^ Connor RC (November 1962). "Complicated
migraine. A study of permanent neurological and visual defects
caused by migraine". Lancet 2 (7265):
1072–5. PMID 14022628.
- ^ Carroll D (April 1970). "Retinal
migraine". Headache 10 (1): 9–13. doi:10.1111/j.1526-4610.1970.hed1001009.x. PMID 5444866.
- ^ McDonald WI, Sanders MD (September 1971).
"Migraine complicated by ischaemic papillopathy". Lancet
2 (7723): 521–3. PMID 4105666.
- ^ Wolter JR, Burchfield WJ (1971). "Ocular
migraine in a young man resulting in unilateral transient blindness
and retinal edema". Pediatr Ophthalmol.
8: 173–6.
- ^ Kline LB, Kelly CL (September 1980).
"Ocular migraine in a patient with cluster headaches".
Headache 20 (5): 253–7. doi:10.1111/j.1526-4610.1980.hed2005253.x. PMID 7451120.
- ^ Corbett JJ. (1983). "Neuro-ophthalmologic
complications of migraine and cluster headaches". Neurol
Clin.: 973–95.
- ^ a
b
Hedges TR (1984). "The terminology of transient
visual loss due to vascular insufficiency". Stroke
15 (5): 907–8. PMID 6474546. http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=6474546.
- ^ "Beneficial effect of carotid
endarterectomy in symptomatic patients with high-grade carotid
stenosis. North American Symptomatic Carotid Endarterectomy Trial
Collaborators". N. Engl. J. Med. 325 (7):
445–53. August 1991. PMID 1852179.
- ^ Lord RS (August 1990). "Transient
monocular blindness". Aust N Z J Ophthalmol
18 (3): 299–305. doi:10.1111/j.1442-9071.1990.tb00624.x. PMID 2261177.
- ^ Donders RC, Dutch Tmb Study Group (August
2001). "Clinical features of
transient monocular blindness and the likelihood of atherosclerotic
lesions of the internal carotid artery". J. Neurol.
Neurosurg. Psychiatr. 71 (2): 247–9. doi:10.1136/jnnp.71.2.247. PMID 11459904. PMC 1737502. http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=11459904.
- ^ Benavente O, Eliasziw M, Streifler JY, Fox
AJ, Barnett HJ, Meldrum H (October 2001). "Prognosis after transient
monocular blindness associated with carotid-artery stenosis".
N. Engl. J. Med. 345 (15): 1084–90. doi:10.1056/NEJMoa002994. PMID 11596587. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11596587&promo=ONFLNS19.
- ^ Rothwell PM, Warlow CP (March 2005). "Timing of TIAs preceding
stroke: time window for prevention is very short".
Neurology 64 (5): 817–20. doi:10.1212/01.WNL.0000152985.32732.EE
(inactive 2009-12-27). PMID 15753415. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15753415.
- ^ a
b
Smit RL, Baarsma GS, Koudstaal PJ
(1994). "The source of embolism in
amaurosis fugax and retinal artery occlusion". Int
Ophthalmol 18 (2): 83–6. doi:10.1007/BF00919244. PMID 7814205. http://www.iovs.org/cgi/reprint/1/1/136.pdf.
- ^ Walsh J, Markowitz I, Kerstein MD (August
1986). "Carotid endarterectomy for
amaurosis fugax without angiography". Am. J. Surg.
152 (2): 172–4. doi:10.1016/0002-9610(86)90236-9. PMID 3526933. http://linkinghub.elsevier.com/retrieve/pii/0002-9610(86)90236-9.
- ^ Bernstein EF, Dilley RB (October 1987).
"Late results after carotid endarterectomy for amaurosis fugax".
J. Vasc. Surg. 6 (4): 333–40. doi:10.1067/mva.1987.avs0060333. PMID 3656582.
|
Pathology of the nervous system, primarily CNS (G04–G47,
323–349) |
|
|
Inflammation |
|
|
Brain/
encephalopathy |
|
|
|
|
|
|
autoimmune
( Multiple
sclerosis, Neuromyelitis optica, Schilder's
disease) · hereditary
( Adrenoleukodystrophy, Alexander,
Canavan, Krabbe, ML, PMD, VWM, MFC,
CAMFAK
syndrome) · Central pontine
myelinolysis · Marchiafava-Bignami
disease · Alpers'
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Spinal cord/
myelopathy |
|
|
|
Both/either |
|
|
| central nervous system navs:
anat/physio/dev, noncongen/congen/neoplasia,
symptoms+signs/eponymous, proc |
|